How much did scientists understand about cancer more than 50 years ago? Today, cancer research involves genome sequencing, molecular targeted therapies, immunotherapy, and sophisticated analyses of cellular metabolism. It is tempting to imagine that cancer biology in 1974 was still at a primitive stage. However, a biochemistry textbook published that year tells a more interesting story.
Recently, we obtained a Japanese biochemistry textbook titled Introduction to Biochemistry (Seikagaku Nyumon), written by Yo Imai and first published by Asakura Publishing in June 1974. Its chapter on cancer biochemistry provides a fascinating record of how researchers understood malignant cells at that time.
The textbook discusses several subjects that remain central to modern cancer biology: uncontrolled proliferation, tumor viruses, cellular transformation, changes in cell membranes, metabolic differences, and altered enzyme activities.
What has changed since 1974? Surprisingly, many of the biological phenomena were already recognized. The major transformation has been our ability to explain these observations through molecular mechanisms.
What Did Scientists Know About Cancer in 1974?
Pages 364–378 of the 1974 textbook contain a section devoted to cancer biochemistry. Rather than presenting cancer simply as uncontrolled cell division, the author discusses a broad range of biological and biochemical abnormalities.
The textbook describes malignant transformation, abnormal proliferation, changes in cell surfaces, tumor-inducing chemicals, radiation, oncogenic viruses, and differences in enzyme activities between normal tissues and tumors.
These observations were important because cancer was already understood as a biological phenomenon involving changes in cellular behavior.
However, the molecular explanation of many of these changes was still incomplete. The modern framework involving oncogenes, tumor suppressor genes, signaling pathways, and genomic instability would develop substantially during the following decades.
Cancer Biology in 1974 vs. Today
The following comparison summarizes selected topics explicitly discussed in the historical textbook and how their interpretation has developed in modern cancer research.
| Topic | 1974 textbook | Modern understanding |
|---|---|---|
| Cell proliferation | Abnormal growth and loss of contact inhibition | Oncogenic signaling, tumor suppressors, and cell-cycle regulation |
| Cancer causes | Chemical carcinogens, radiation, and viruses | Genetic, epigenetic, environmental, and infectious mechanisms |
| Tumor viruses | DNA and RNA tumor viruses and cellular transformation | Viral oncogenes, genome integration, and virus-associated cancers |
| Cell membranes | Changes in surface properties, permeability, and cell interactions | Cell adhesion, receptor signaling, glycosylation, and tumor microenvironment interactions |
| Cancer metabolism | Altered metabolic activities and enzyme patterns | Context-dependent metabolic reprogramming and metabolic heterogeneity |
| Liver tumors | Comparisons of enzyme activities in experimental liver tumors | Molecular classification and integrated genomic, proteomic, and metabolomic analysis |
The comparison reveals an important distinction. Scientists in 1974 had already identified numerous characteristics of cancer cells. What changed was not simply the discovery of these characteristics, but the development of molecular explanations and more powerful experimental methods.
Did Scientists Know That Viruses Could Cause Cancer?
Yes. The connection between viruses and cancer was already an established research topic by 1974.
The historical textbook describes oncogenic DNA and RNA viruses, including examples associated with experimental tumor formation. Rous sarcoma virus, originally identified through studies of tumors in chickens, had already become an important model for investigating malignant transformation.
An especially important development occurred in 1970, when Howard Temin and David Baltimore independently demonstrated reverse transcriptase activity in RNA tumor viruses. This discovery provided a molecular explanation for how genetic information from an RNA virus could be copied into DNA.
The discovery was so influential that Baltimore, Temin, and Renato Dulbecco received the 1975 Nobel Prize in Physiology or Medicine for their work on tumor viruses and cellular genetic material.
However, an important part of the modern understanding of cancer genes emerged after the textbook was published. In 1976, researchers demonstrated that normal chicken cells contain DNA sequences related to the oncogene of an avian sarcoma virus. This finding helped establish the concept that cancer-causing genes can originate from normal cellular genes rather than being exclusively viral inventions.
The distinction is historically important. The 1974 textbook belongs to a period when tumor virology was advancing rapidly, but the modern genetic framework of cancer was still developing.
How Did Scientists Understand Cancer Cell Growth?
The textbook discusses abnormal cellular proliferation and changes in contact inhibition.
Contact inhibition refers to the tendency of many normal cultured cells to reduce proliferation when they encounter neighboring cells and reach high density. Loss of this behavior was an important experimental feature used to study transformed cells.
In 1974, researchers could observe altered cellular growth and morphology, but the precise molecular mechanisms responsible for these changes were not yet fully characterized.
Modern cancer biology explains abnormal proliferation through interconnected pathways involving growth-factor receptors, intracellular signaling, cell-cycle regulators, and tumor suppressor proteins.
Nevertheless, contact inhibition remains a useful historical and experimental concept. Its loss is not a universal diagnostic criterion for every cancer, and tumor growth cannot be explained by this property alone.
Cancer Metabolism: What Was Already Known in 1974?
One of the most interesting sections of the textbook concerns cancer metabolism.
Today, altered cellular metabolism is widely recognized as an important feature of cancer. However, the observation that tumor cells differ metabolically from normal cells is much older than modern metabolomics.
During the early twentieth century, Otto Warburg investigated the metabolic properties of tumor tissues. His work helped establish the phenomenon now called the Warburg effect: many cancer cells exhibit increased glucose consumption and lactate production even when oxygen is available.
This phenomenon is also known as aerobic glycolysis.
By 1974, cancer researchers were already investigating metabolic differences between malignant and normal tissues. The historical textbook discusses changes in enzyme activities, metabolic patterns, and the relationship between cellular proliferation and biochemical processes.
Thus, the concept that cancer involves altered metabolism was not a discovery of the twenty-first century.
What Is the Warburg Effect?
Under many conditions, cells can generate ATP through glycolysis and mitochondrial oxidative phosphorylation. Glycolysis converts glucose into pyruvate, while mitochondrial metabolism can further oxidize carbon substrates to support ATP production.
Many cancer cells exhibit substantial glucose uptake and lactate production despite the availability of oxygen.
At first glance, this seems inefficient because complete glucose oxidation can produce considerably more ATP per glucose molecule than conversion of glucose to lactate.
However, rapidly proliferating cells need more than ATP. They also require carbon skeletons, reducing equivalents, nucleotides, amino acids, and lipids to build new cellular components.
A widely cited review by Vander Heiden and colleagues discusses the relationship between aerobic glycolysis and the metabolic requirements of cell proliferation [1].
Importantly, the Warburg effect does not mean that all cancer cells have defective mitochondria. Many tumors retain functional mitochondrial metabolism, and cancer cells can use multiple energy-producing pathways.
What Has Changed in Cancer Metabolism Research Since 1974?
The most important development is the recognition that cancer metabolism is highly diverse.
Different tumors can exhibit different metabolic dependencies. Even cells within the same tumor may display distinct metabolic states depending on oxygen availability, nutrient supply, genetic alterations, and interactions with surrounding cells.
Modern studies therefore investigate cancer metabolism as a dynamic network rather than a single abnormal pathway shared by every tumor.
Pavlova, Zhu, and Thompson reviewed the emerging characteristics of cancer metabolism in 2022, emphasizing the complexity of metabolic adaptations associated with malignant growth [2].
This perspective also changes how the Warburg effect should be interpreted. Increased glycolysis is important in many cancers, but it cannot serve as a complete description of cancer metabolism.
For example, cancer cells may depend on glucose, glutamine, fatty acids, or other nutrients under different biological conditions.
The metabolic behavior of a tumor can also change during progression, treatment, or adaptation to its microenvironment.
What Did the 1974 Textbook Say About Liver Cancer?
The final part of the historical chapter examines biochemical alterations in experimental liver tumors.
Pages 374–378 discuss changes in enzyme activities and compare biochemical characteristics of liver tumors with those of normal liver tissue.
Particular attention is given to experimental observations involving metabolic enzymes and the relationship between enzyme activity patterns and tumor characteristics.
These discussions reflect an important research strategy of the period: measuring the activities of selected enzymes to characterize the biochemical state of tumor tissues.
Today, cancer metabolism can be investigated using combinations of metabolomics, proteomics, transcriptomics, genome sequencing, isotope tracing, and computational modeling.
These approaches provide information about molecular abundance, pathway regulation, and metabolic flux that cannot be obtained from individual enzyme activity measurements alone.
Nevertheless, the central scientific question is remarkably similar: how does malignant transformation alter cellular metabolism?
The historical liver tumor studies discussed in the textbook should not be interpreted as evidence that every cancer shares the same enzyme activity changes. Different tumor models and tissue types can exhibit substantially different metabolic behavior.
Why Modern Cancer Research Is Different
The distinction between cancer research in 1974 and today can be summarized in three major developments.
1. From Cellular Observations to Molecular Mechanisms
Researchers in 1974 could characterize cancer cells through morphology, growth behavior, biochemical reactions, and enzyme activities. Modern molecular biology connects many of these observations to specific genetic alterations, regulatory proteins, and signaling pathways.
2. From Individual Enzymes to Molecular Networks
Historical cancer biochemistry frequently examined individual metabolic enzymes and their activities. Modern systems biology can investigate thousands of molecular features simultaneously, helping researchers analyze how metabolic pathways interact across different cellular states.
3. From a General Cancer Model to Tumor Heterogeneity
Cancer is not a single disease with one universal molecular mechanism. Different tumor types, and even different regions of the same tumor, can exhibit distinct genetic, biochemical, and metabolic characteristics.
This diversity has become an important consideration in cancer research and therapeutic development. Hanahan's 2022 review, Hallmarks of Cancer: New Dimensions, provides a modern conceptual framework for understanding the complexity of cancer biology [3].
Was Cancer Biology in 1974 Already Advanced?
Reading the historical textbook suggests that the answer is more nuanced than a simple yes or no.
Researchers had already identified many fundamental features of malignant cells. Tumor viruses, abnormal growth, cell-surface alterations, and differences in metabolism were active subjects of scientific investigation.
At the same time, the genetic and molecular mechanisms underlying many of these phenomena remained incompletely understood.
The following decades brought discoveries concerning cellular oncogenes, tumor suppressor genes, growth signaling, genome alterations, and the molecular diversity of tumors.
These developments did not simply replace the observations made by earlier scientists. Instead, they provided increasingly detailed explanations for many of those observations.
Why Historical Biochemistry Textbooks Still Matter
Scientific textbooks are records of what was understood, emphasized, and considered uncertain at the time of publication.
A textbook from 1974 does not provide a complete description of current cancer biology. However, it offers a valuable perspective on the development of scientific knowledge.
Comparing historical explanations with modern research helps distinguish long-established observations from mechanisms that were discovered later.
It also reminds us that contemporary scientific models are products of a continuing process of experimentation, revision, and refinement.
The historical book examined here is Seikagaku Nyumon (Introduction to Biochemistry), written by Yo Imai and published by Asakura Publishing in 1974. The discussion focuses on the chapter section titled Cancer Biochemistry, pages 364–378.
Conclusion
What did scientists know about cancer in 1974? More than we might initially expect.
The historical textbook demonstrates that researchers were already investigating abnormal cell growth, tumor viruses, changes in cell membranes, metabolic differences, and altered enzyme activities.
Modern cancer research has greatly expanded our understanding of the molecular mechanisms underlying these phenomena, particularly through genetics, molecular biology, and systems-level analysis.
Perhaps the most interesting conclusion is that many important questions in cancer biology have remained recognizable for more than half a century, even though the methods used to answer them have changed dramatically.
Historical science is not simply a collection of outdated explanations. It is a record of how today's scientific questions and concepts developed.
Frequently Asked Questions
Was cancer understood in 1974?
Scientists in 1974 understood several important characteristics of cancer cells, including abnormal proliferation, altered metabolism, and the involvement of some viruses in tumor formation. However, many molecular mechanisms involving oncogenes and tumor suppressor genes were clarified later.
When was the Warburg effect discovered?
Otto Warburg investigated the unusual metabolic behavior of tumor tissues during the 1920s. His work helped establish the observation that many tumor cells produce substantial amounts of lactate even when oxygen is available.
Did scientists know about cancer-causing viruses in 1974?
Yes. Tumor viruses were an established research topic by 1974. Reverse transcriptase had already been discovered in 1970, providing important insights into RNA tumor viruses.
What is the biggest difference between cancer research in 1974 and today?
One major difference is the ability to investigate cancer at the molecular and systems levels. Modern research can connect cellular behavior and metabolism to genetic alterations, signaling pathways, and interactions within the tumor microenvironment.
Do all cancer cells show the Warburg effect?
No. Although increased aerobic glycolysis is common in many cancers, tumors exhibit substantial metabolic diversity. Cancer cells may also depend on mitochondrial oxidative phosphorylation and other metabolic pathways.
References
- Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033. DOI: 10.1126/science.1160809.
- Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metabolism. 2022;34:355–377. DOI: 10.1016/j.cmet.2022.01.007.
- Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discovery. 2022;12:31–46. DOI: 10.1158/2159-8290.CD-21-1059.
- Hughes SH. The Discovery of Reverse Transcriptase. Annual Review of Virology. 2016;3:1–19. DOI: 10.1146/annurev-virology-110615-035556.
- National Cancer Institute. Milestones in Cancer Research and Discovery. Historical timeline of major discoveries in cancer research.
- Imai Y. Seikagaku Nyumon (Introduction to Biochemistry). Tokyo: Asakura Publishing; 1974. Section 12.4, Cancer Biochemistry, pp. 364–378. Historical primary source.